The official blog of the Lung Institute.

Lung Institute Gets the Public’s Attention through the Revealing Insight into a Day in the Life of a COPD Sufferer

7 Nov 2013
| Under Press | Posted by | 0 Comments
Life of a COPD Sufferer

This Initiative is in Support of COPD Awareness Month

Tampa, Fla. (November 7, 2013) – In support of COPD Awareness Month and the US COPD Coalition, the entire month of November, the Lung Institute is raising awareness for COPD through factual and insightful social media posts as well as blog articles. This week, the Lung Institute aims to get the public’s attention through a candid glimpse into the life of a COPD sufferer.

Although COPD is the third leading cause of death in the United States and top five leading cause of death in the world, many people are still unaware of this deadly disease. Currently, more than 11 million people have been diagnosed with COPD. However, nearly 24 million U.S. adults may have the disease without even knowing it.

Because of these alarming statistics, spreading the word about COPD is essential for treatment and prevention. This week’s article by the Lung Institute gives insight into the life of a COPD sufferer before and after receiving stem cell treatments at the Lung Institute. Peter P. is 68-years-old and has COPD. He has experienced life-altering symptoms for many years.

If you had asked Peter to describe his daily routine a year ago, he would tell you that it took him 30 minutes to take a shower, that he had difficulty walking and that he felt winded when playing with his grandchildren. Besides the physical symptom of shortness of breath, like many people with COPD, Peter would tell you that his quality of life had been significantly impacted.

After receiving stem cell treatments, Peter is feeling considerably better. His 30 minute showers now take less than 15 minutes, he is able to walk and get around without the constant use of supplemental oxygen and he is able to play with his grandchildren without feeling short of breath. Overall, Peter feels that his quality of life has improved significantly.

“My exercise tolerance has gotten better. I can exercise longer and make it a little harder every day. I try to do a minimum of 45 minutes. My wife tells me my disposition is better. I’ve got my voice back. I’ve got more power in my voice, which I didn’t have before. It’s been a positive experience,” Peter said.

About Lung Institute

The Lung Institute is a leading medical provider of regenerative cellular therapy for lung diseases such as COPD, pulmonary fibrosis and interstitial lung disease. Founded in 2013 in Tampa, Fla., the Lung Institute currently has clinics in Tampa, Fla., Nashville, Tenn., Scottsdale, Ariz., Pittsburgh, Pa. and Dallas, Texas. For more information, please visit www.lunginstitute.com or call (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.